Literature DB >> 9753064

CD20-positive T-cell chronic lymphocytic leukaemia.

A Takami1, M Saito, S Nakao, H Asakura, T Nozue, Y Onoe, A Yachie, S Shiobara, T Matsuda.   

Abstract

Although CD20 is considered to be a representative marker for B lymphocytes, the antigen is weakly expressed on a small subset of normal T lymphocytes. A 60-year-old man developed pancytopenia and hepatosplenomegaly due to clonal proliferation of atypical lymphocytes that were weakly positive for CD20. The leukaemic cells were also positive for T-cell antigens such as CD2, CD3, CD5, CD7, CD8 and T-cell receptor (TCR) Vbeta8 and for activation antigens such as CD38 and HLA-DR, but were negative for CD19, CD21, CD22, CD25. Southern blot analysis revealed rearrangement of the TCR-beta gene and a germline configuration of the immunoglobulin heavy chain gene. This is the first report of a case of clonal expansion of CD20dim T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9753064

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

Review 1.  CD20 positive T cell lymphoma: is it a real entity?

Authors:  T Sun; A Akalin; M Rodacker; T Braun
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

2.  Primary mediastinal anaplastic alk-1-positive large-cell lymphoma of T/NK-cell type expressing CD20.

Authors:  J Gonin; H Kadiri; S Bensaci; A Le Tourneau; T J Molina; J Diebold; D J Abdellouche; J Audouin
Journal:  Virchows Arch       Date:  2007-01-25       Impact factor: 4.064

3.  Multispectral Imaging Approach to the Diagnosis of a CD20+ Cutaneous T-cell Lymphoproliferative Disorder: A Case Report.

Authors:  Katrin A Salva; Daniel Bennett; Jack Longley; Joan Guitart; Gary S Wood
Journal:  Am J Dermatopathol       Date:  2015-10       Impact factor: 1.533

4.  CD20- and CD56-positive T-cell large granular lymphocyte leukemia in a human T-cell leukemia virus type 1 carrier.

Authors:  Sonoko Nakano-Akamatsu; Ryoichi Takahashi; Yukiko Sekioka; Yohei Hosokawa; Tohru Inaba
Journal:  Int J Hematol       Date:  2007-11       Impact factor: 2.490

Review 5.  CD20-positive NK/T-cell lymphoma with indolent clinical course: report of case and review of literature.

Authors:  Qing-ping Jiang; Shao-yan Liu; Yue-xin Yang; Xue-xian Tan; Juan Peng; Zhong-tang Xiong; Zhi Li
Journal:  Diagn Pathol       Date:  2012-10-02       Impact factor: 2.644

6.  Peripheral T-Cell Lymphoma with Aberrant Expression of CD19, CD20, and CD79a: Case Report and Literature Review.

Authors:  Rahul G Matnani; Rachel L Stewart; Joseph Pulliam; Chester D Jennings; Melissa Kesler
Journal:  Case Rep Hematol       Date:  2013-08-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.